Clinical Trial

Safety and Efficacy of Levofloxacin for Acute Ischemic Stroke

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 2, 2024 (before its estimated December 30, 2024 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to determine the efficacy and safety of levofloxacin in treating acute ischemic stroke.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-03-23; most recent amendment 2024-10-01.
Status change: Not Yet Recruiting → Recruiting 2023-09-13
Trial Details
NCT Number NCT05799326
Lead Sponsor Yi Yang
Conditions Acute Ischemic Stroke
Enrollment 100 participants
Start Date 2023-06-30
Primary Completion 2024-12-30 (estimated)
Study Completion 2024-12-30 (estimated)
Updated on ClinicalTrials.gov 2024-10-02